The Effect of 5-hydroxytryptophan on ADHD Traits and Eye Movements
Key facts
- Who runs it
- University of Sheffield
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 25 Nov 2025
- Expected to end
- Jun 2027
- Type of study
- Interventional, 6 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 5-hydroxytryptophan (food supplement) 200mg
- 5-hydroxytryptophan (food supplement) 300mg
- Placebo
- Record updated
- 20 August 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- 18-65 years of age
- Normal or corrected to normal vision with contact lenses
- Score of <9 or >14 on the ASRS v5 (assessed in pre screen questionnaire)
Who cannot take part
- Current use of psychostimulant medication or medication for the treatment of ADHD
- Current use of medications known to impact the serotonergic system (e.g., SSRIs)
- Smoking or vaping
- Pregnancy
- Breast feeding
- Lactose intolerance
- Veganism
- Dyslexia
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this project is to look at the impact of 5-Hydroxytryptophan (5-HTP) on distractibility. 5-HTP is the precursor to the neurotransmitter serotonin and is a chemical that the body produces naturally. There is evidence that distractibility is associated with a decreased level of serotonin. This research aims to see if giving people 5-HTP will alter their distractibility, which will form part of an initial assessment as to whether 5-HTP could be used to support people with attention problems. The study involves completing a short survey about mental health and behaviours, and if eligible, participation in an in-person study at the University of Sheffield. The in-person session involves completing some cognitive tasks to look at eye movement, taking 5-HTP or a sugar tablet with no active ingredients, and then completing the tasks again after a 90-minute wait.
The 6 groups in the trial
- High ADHD traits - 200mg 5-HTPTreatment being tested
Participants who have reported high levels of ADHD traits, and have been randomly allocated to the group receiving 200 mg 5-HTP, administered orally in tablet form.
Treatment: 5-hydroxytryptophan (food supplement) 200mg
- High ADHD traits - 300mg 5-HTPTreatment being tested
Participants who have reported high levels of ADHD traits, and have been randomly allocated to the group receiving 300 mg 5-HTP, administered orally in tablet form.
Treatment: 5-hydroxytryptophan (food supplement) 300mg
- High ADHD traits - PlaceboPlacebo, for comparison
Participants who have reported high levels of ADHD traits, and have been randomly allocated to the group receiving placebo. Placebo consists of 2 sucrose-lactose tablets, administered orally.
Treatment: Placebo
- Low ADHD traits - 200mg 5-HTPExisting treatment, for comparison
Participants who have reported low levels of ADHD traits, and have been randomly allocated to the group receiving 200 mg 5-HTP, administered orally in tablet form.
Treatment: 5-hydroxytryptophan (food supplement) 200mg
- Low ADHD traits - 300mg 5-HTPExisting treatment, for comparison
Participants who have reported low levels of ADHD traits, and have been randomly allocated to the group receiving 300 mg 5-HTP, administered orally in tablet form.
Treatment: 5-hydroxytryptophan (food supplement) 300mg
- Low ADHD traits - placeboPlacebo, for comparison
Participants who have reported low levels of ADHD traits, and have been randomly allocated to the group receiving placebo. Placebo consists of 2 sucrose-lactose tablets, administered orally.
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of 5-hydroxytryptophan on Microsaccades and Distractibility in Individual With High Levels of ADHD Traits: a Randomised, Double-blind Trial
- Fit questions
- Built from NCT07777328, who can take part
- Record updated
- 20 August 2026